• CME Group and Silicon Data have already announced plans to launch a first-in-class compute futures market later in 2026, pending regulatory review, using Silicon Data’s daily GPU rental-rate indices to bring standardized pricing and risk management to the multi-trillion-dollar compute market.
• This move effectively treats computing power as a tradable asset class, potentially reshaping how AI builders, cloud providers and financial institutions plan and hedge long-term infrastructure costs.
• We’ll now explore how CME’s push into GPU-based compute futures could alter its investment narrative built around innovation and diversified derivatives growth.

Capitalize on the AI infrastructure supercycle with our selection of the 39 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

CME Group Investment Narrative Recap

To own CME Group, you generally need to believe in the long term importance of deep, centralized derivatives markets and CME’s ability to keep adding relevant contracts as trading needs evolve. The compute futures launch with Silicon Data fits that story of product innovation, but it does not obviously change the near term reliance on interest rate and equity futures or the key risk that quieter markets and lower volatility could weigh on volumes.

Among recent announcements, the launch of Bitcoin Volatility futures is especially relevant. Like compute futures, it extends CME’s role in risk transfer for newer asset types by giving institutions a regulated way to trade a specific risk factor, in this case bitcoin volatility instead of price, which ties directly into the catalyst of diversified derivatives growth beyond traditional rate and equity contracts.

Yet while these new contracts broaden CME’s reach, investors should also weigh the risk that alternative low fee or decentralized venues could...

CME Group's narrative projects $7.8 billion revenue and $4.6 billion earnings by 2029.

Uncover how CME Group's forecasts yield a $308.20 fair value, a 4% upside to its current price.

Exploring Other Perspectives

Four fair value estimates from the Simply Wall St Community span roughly US$246 to US$308 per share, highlighting how differently individual investors assess CME’s prospects. Against that wide range, CME’s expansion into areas like compute and crypto derivatives raises important questions about how product breadth may influence future trading volumes and competitive pressures, which readers may want to explore through several contrasting views.

Explore 4 other fair value estimates on CME Group - why the stock might be worth 17% less than the current price!

Form Your Own Verdict

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your CME Group research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
• Our free CME Group research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate CME Group's overall financial health at a glance.

Want Some Alternatives?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

• Uncover the next big thing with 28 elite penny stocks that balance risk and reward.
• AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• The future of work is here. Discover the 30 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.